The Aperlena Verdict
Open raceNo supplier dominates: 109 different companies have won the last 145 comparable contracts from this buyer over 5 years. This is a genuinely open race.
Based on 145 comparable awards by this buyer in this sector over 5 years. Every verdict is recorded before the outcome and graded against the award notice. How we score ourselves.
Summary
Machine-generated summaryProcurement of medicines in Estonia covering several groups of active substances: antipsychotic medicines; dermatological medicines; medicines acting on the respiratory system, including ephedrine; anti-anaemia medicines such as iron(II) sulphate, iron(III) hydroxide sucrose complex or iron(III) hydroxide dextran complex, dextransferon or iron(III) derisomaltose, erythropoietin; and peripherally acting muscle relaxants. Dermatological substances include silver sulfadiazine, clotrimazole, clobetasol, betamethasone plus fusidic acid, dexpanthenol, isoconazole plus diflucortolone and mometasone, as well as methylprednisolone aceponate. The procurement is divided into separate lots per active substance. Exclusion grounds and qualification conditions are set out in the procurement documents.
Description
Bid or no-bid?
Six questions before you commit a team. Under each one, what the register holds on it. The answers are yours.
Can I bid?
- Open procedure: any interested supplier may submit a bid. Above the EU threshold: open to companies from any EU country.
- The notice is written in Estonian.
- Certificates from another EU country? Check the equivalents on eCertis
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Report an error in this notice
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 2 hours ago
What this buyer has paid before
Based on 14 comparable contracts this buyer awarded in this sector over the last 4 years.
- This notice
- €3.0M
- Median award
- €313,782
- Middle half of past awards
- €124,011 to €437,760
The estimate is larger than three in four past awards.
Most recent awards
- Medicines - Hospital medicines - September 2026 €415,814
- Medicines - Hospital medicines - August 2026 €1,028,369
- Eesti - Ravimid - 311832 Haiglaravimid - juuni 2026 2 €316,036
- Eesti - Ravimid - Haiglaravimid - juuni 2026 €24,418
- Eesti - Ravimid - Haiglaravimid - aprill 2026 €311,528
Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.
The buyer
Full buyer profilesihtasutus Põhja-Eesti Regionaalhaigla
- notices in the register
- 455
- awards
- 226
- awarded in total
- €16.6M
Who wins its contracts
Many suppliers- different companies won its awards
- 158
- of the awards went to the three most frequent winners
- 6%
- of its calls state an estimated value
- 93%
Based on 200 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.
Competition
- tenders per lot on average (open and restricted procedures)
- 1.8
- of those lots received a single tender
- 39%
- of the awards went to companies based in another country
- 12%
As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.
Who usually wins this buyer's contracts in this sector
| Company | Wins | Total awarded | Last win |
|---|---|---|---|
| AB Medical Group Eesti osaühing | 4 | Mar 2026 | |
| AKTSIASELTS MEDITSIINIGRUPP | 4 | Dec 2025 | |
| Quantum Eesti AS | 4 | Aug 2026 | |
| Abbott Medical Estonia OÜ | 3 | Jun 2026 | |
| aktsiaselts SEMETRON | 3 | Jun 2026 |
Based on 145 awards with a linked company profile over the last 5 years.
5 open tenders right now
Market context
Larger than 87% of the open notices in Medical equipment & pharmaceuticals across Europe.
- open now in Medical equipment & pharmaceuticals
- 11,274
- median open notice
- €140,000
Who wins in this market
Many suppliersEstonia · Medical equipment & pharmaceuticals
- different companies won awards here
- 346
- of the awards went to the three most frequent winners
- 13%
- buyers awarded contracts here
- 52
Based on 668 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.
Competition
- tenders per lot on average (open and restricted procedures)
- 1.7
- of those lots received a single tender
- 36%
- of the awards went to companies based in another country
- 8%
- of the tenders came from another country
- 19%
As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.
Similar tenders
Open now
13
days left
€2,860,000
est. value
25
days left
€26,513,000
est. value
Awarded before
Never miss a tender like this
17 new notices in Medical equipment & pharmaceuticals in Estonia in the last 7 days. Get an email when new ones appear. Free.
Set up my alert